TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN

摘要

The present invention relates to a topical composition comprising erlotinib and a pharmaceutically acceptable excipient for use in the treatment of a keratoderma in a child, preferably a palmoplantar keratoderma (PPK), wherein the composition is topically administered. According to one embodiment, the composition further comprises a penetration enhancer. According to one embodiment, the treated subject is younger than three years old. The present invention also relates to woven or non-woven fabric support comprising erlotinib and to dressings, patches, gloves and socks comprising the support useful in the treatment of a PPK.